Global Pharmaceuticals & Biotech Big Green Snowflakes

OWC Pharmaceutical Research

Market Cap: US$497.0

Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.

Sailong Pharmaceutical GroupLtd

Market Cap: CN¥2.6b

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China.

Halo Collective

Market Cap: US$150.0

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

Ensol Biosciences

Market Cap: ₩224.6b

A biopharmaceutical company, develops bio drugs for the treatment of degenerative disc, osteoarthritis, cancer, type 1 diabetes, and Alzheimer's dementia diseases.

J. Molner

Market Cap: €44.8m

A pharmaceutical company, provides research and development services for pharmaceutical companies in the United States, Canada, and Europe.

Eloxx Pharmaceuticals

Market Cap: US$330.0

A clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases.

Nouveau Life Pharmaceuticals

Market Cap: US$6.7k

A development stage company, engages in the development of nutraceuticals products.

White Label Liquid

Market Cap: US$6.4k

Provides manufacturing service for custom-blended products containing hemp-derived CBD oil.

Eagle Pharmaceuticals

Market Cap: US$40.2m

A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.

FullHope BiomedicalLtd

Market Cap: NT$1.7b

Engages in the research and development of immune system-related services.

Ayala Pharmaceuticals

Market Cap: US$1.6m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

G-H-3 International

Market Cap: US$0

Develops products for addressing factors, which cause aging and deterioration in the body.

Rebus Holdings

Market Cap: US$3.2k

Focuses on the research and development of precision therapeutics for the treatment of cancer.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

AVAX Technologies

Market Cap: US$6.9k

A development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

WOWI

Market Cap: US$6.6k

An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.

Itonis

Market Cap: US$457.0k

A development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases.

Theralink Technologies

Market Cap: US$6.2k

A commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States.

Nanobac Pharmaceuticals

Market Cap: US$249.0

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs).

Neurobiological Technologies

Market Cap: US$2.7k

Operates under a plan of liquidation and dissolution approved by stockholders in October 2009.

PRISM BioLabLTD

Market Cap: JP¥6.5b

A biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases.

Median Diagnostics

Market Cap: ₩21.8b

Develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals and human.

Vidipha Central Pharmaceutical

Market Cap: ₫984.9b

Produces and sells pharmaceutical products under the Vidipha brand.

Dong Sung Bio Pharm.Co.Ltd

Market Cap: ₩23.2b

Manufactures and sells pharmaceuticals and cosmetics in South Korea.

Quantum Genomics Société Anonyme

Market Cap: €5.0m

A healthtech company, develops of drugs to treat cardiovascular diseases.

Korea United Pharm

Market Cap: ₩303.1b

Engages in the manufacture and sale of pharmaceutical products in South Korea.

Choong Ang Vaccine Laboratory

Market Cap: ₩90.4b

Operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea.

Regenicin

Market Cap: US$15.3k

Focuses on developing and commercializing a technology of tissue-engineered skin substitutes.

Procaps Group

Market Cap: US$2.6b

Develops, produces, and markets pharmaceutical solutions worldwide.

DNAPrint Genomics

Market Cap: US$1.3k

Engages in the development and marketing of genetic testing products and services.